Peripheral vascular occlusive disease in renal transplant recipients: Riskfactors and impact on kidney allograft survival

Citation
Rs. Sung et al., Peripheral vascular occlusive disease in renal transplant recipients: Riskfactors and impact on kidney allograft survival, TRANSPLANT, 70(7), 2000, pp. 1049-1054
Citations number
22
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
70
Issue
7
Year of publication
2000
Pages
1049 - 1054
Database
ISI
SICI code
0041-1337(20001015)70:7<1049:PVODIR>2.0.ZU;2-0
Abstract
Background. This study evaluated the relationship between renal transplanta tion and the evolution of lower extremity peripheral vascular occlusive dis ease (PVOD). Methods. A total of 664 adult renal allograft recipients from 1985-1995 wer e retrospectively reviewed for atherosclerotic risk factors and peripheral vascular occlusive disease (PVOD). PVOD events were defined as by-pass, maj or amputation, claudication, or percutaneous angioplasty. Follow-up ranged from 2-12 years. Results. The cumulative 5- and 10-year incidences of lower extremity PVOD a fter renal transplantation were 4.2 and 5.9%. Eight of 14 patients (57%) wi th pretransplant PVOD had additional PVOD events versus de novo appearance of PVOD in 21/650 patients (3.2%; P<0.0001). In a proportional hazards mode l, age, preoperative PVOD, diabetes, and postoperative smoking were indepen dent risk factors for the development of PVOD after transplantation. Recipi ents with lower extremity PVOD had significantly lower 10-year patient and graft survival. Increased graft failure was due to an excess of deaths with a functioning graft. A total of 34 major interventions were performed. One - and two-year limb salvage rates were 64.2 and 53.8%. Conclusions. Lower extremity PVOD after renal transplantation is associated with diminished patient survival, and affects kidney graft survival via di sproportionate patient attrition. Age, preoperative PVOD, diabetes, and pos toperative smoking are important risk factors. Transplantation does not app ear to either accelerate or retard the progression of disease. An aggressiv e approach towards limb salvage in properly selected patients is justifiabl e.